<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">22926519</PMID><DateCompleted><Year>2013</Year><Month>08</Month><Day>14</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1476-5594</ISSN><JournalIssue CitedMedium="Internet"><Volume>32</Volume><Issue>24</Issue><PubDate><Year>2013</Year><Month>Jun</Month><Day>13</Day></PubDate></JournalIssue><Title>Oncogene</Title><ISOAbbreviation>Oncogene</ISOAbbreviation></Journal><ArticleTitle>Far upstream element binding protein 1: a commander of transcription, translation and beyond.</ArticleTitle><Pagination><StartPage>2907</StartPage><EndPage>2916</EndPage><MedlinePgn>2907-16</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/onc.2012.350</ELocationID><Abstract><AbstractText>The far upstream binding protein 1 (FBP1) was first identified as a DNA-binding protein that regulates c-Myc gene transcription through binding to the far upstream element (FUSE) in the promoter region 1.5&#x2009;kb upstream of the transcription start site. FBP1 collaborates with TFIIH and additional transcription factors for optimal transcription of the c-Myc gene. In recent years, mounting evidence suggests that FBP1 acts as an RNA-binding protein and regulates mRNA translation or stability of genes, such as GAP43, p27(Kip) and nucleophosmin. During retroviral infection, FBP1 binds to and mediates replication of RNA from Hepatitis C and Enterovirus 71. As a nuclear protein, FBP1 may translocate to the cytoplasm in apoptotic cells. The interaction of FBP1 with p38/JTV-1 results in FBP1 ubiquitination and degradation by the proteasomes. Transcriptional and post-transcriptional regulations by FBP1 contribute to cell proliferation, migration or cell death. FBP1 association with carcinogenesis has been reported in c-Myc dependent or independent manner. This review summarizes biochemical features of FBP1, its mechanism of action, FBP family members and the involvement of FBP1 in carcinogenesis.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, University of Arizona, Tucson, AZ 85724, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Q M</ForeName><Initials>QM</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 HL076530</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 ES007091</GrantID><Acronym>ES</Acronym><Agency>NIEHS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HL 076530</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21ES017473</GrantID><Acronym>ES</Acronym><Agency>NIEHS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HL089958</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21 ES017473</GrantID><Acronym>ES</Acronym><Agency>NIEHS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2012</Year><Month>08</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Oncogene</MedlineTA><NlmUniqueID>8711562</NlmUniqueID><ISSNLinking>0950-9232</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C492258">FUBP1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016601">RNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.4.-</RegistryNumber><NameOfSubstance UI="D004265">DNA Helicases</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004265" MajorTopicYN="N">DNA Helicases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005786" MajorTopicYN="N">Gene Expression Regulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014176" MajorTopicYN="Y">Protein Biosynthesis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016601" MajorTopicYN="N">RNA-Binding Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014158" MajorTopicYN="Y">Transcription, Genetic</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement><b>CONFLICT OF INTEREST</b>. The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2012</Year><Month>8</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2012</Year><Month>8</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2013</Year><Month>8</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2016</Year><Month>8</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">22926519</ArticleId><ArticleId IdType="mid">NIHMS805428</ArticleId><ArticleId IdType="pmc">PMC4968413</ArticleId><ArticleId IdType="doi">10.1038/onc.2012.350</ArticleId><ArticleId IdType="pii">onc2012350</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>de Nigris F, Sica V, Herrmann J, Condorelli G, Chade AR, Tajana G, et al. c-Myc oncoprotein: cell cycle-related events and new therapeutic challenges in cancer and cardiovascular diseases. Cell Cycle. 2003;2:325&#x2013;328.</Citation><ArticleIdList><ArticleId IdType="pubmed">12851483</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffman B, Liebermann DA. Apoptotic signaling by c-MYC. Oncogene. 2008;27:6462&#x2013;6472.</Citation><ArticleIdList><ArticleId IdType="pubmed">18955973</ArticleId></ArticleIdList></Reference><Reference><Citation>Levens D. Disentangling the MYC web. Proc Natl Acad Sci USA. 2002;99:5757&#x2013;5759.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC122847</ArticleId><ArticleId IdType="pubmed">11983876</ArticleId></ArticleIdList></Reference><Reference><Citation>Pelengaris S, Khan M, Evan G. c-MYC: more than just a matter of life and death. Nat Rev Cancer. 2002;2:764&#x2013;776.</Citation><ArticleIdList><ArticleId IdType="pubmed">12360279</ArticleId></ArticleIdList></Reference><Reference><Citation>Avigan MI, Strober B, Levens D. A far upstream element stimulates c-myc expression in undifferentiated leukemia cells. J Biol Chem. 1990;265:18538&#x2013;18545.</Citation><ArticleIdList><ArticleId IdType="pubmed">2211718</ArticleId></ArticleIdList></Reference><Reference><Citation>Duncan R, Bazar L, Michelotti G, Tomonaga T, Krutzsch H, Avigan M, et al. A sequence-specific, single-strand binding protein activates the far upstream element of c-myc and defines a new DNA-binding motif. Genes Dev. 1994;8:465&#x2013;480.</Citation><ArticleIdList><ArticleId IdType="pubmed">8125259</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J, Kouzine F, Nie Z, Chung HJ, Elisha-Feil Z, Weber A, et al. The FUSE/FBP/FIR/TFIIH system is a molecular machine programming a pulse of c-myc expression. EMBO J. 2006;25:2119&#x2013;2130.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1462968</ArticleId><ArticleId IdType="pubmed">16628215</ArticleId></ArticleIdList></Reference><Reference><Citation>Chien HL, Liao CL, Lin YL. FUSE binding protein 1 interacts with untranslated regions of Japanese encephalitis virus RNA and negatively regulates viral replication. J Virol. 2011;85:4698&#x2013;4706.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3126168</ArticleId><ArticleId IdType="pubmed">21367899</ArticleId></ArticleIdList></Reference><Reference><Citation>Irwin N, Baekelandt V, Goritchenko L, Benowitz LI. Identification of two proteins that bind to a pyrimidine-rich sequence in the 3&#x2019;-untranslated region of GAP-43 mRNA. Nucleic Acids Res. 1997;25:1281&#x2013;1288.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC146556</ArticleId><ArticleId IdType="pubmed">9092640</ArticleId></ArticleIdList></Reference><Reference><Citation>Olanich ME, Moss BL, Piwnica-Worms D, Townsend RR, Weber JD. Identification of FUSE-binding protein 1 as a regulatory mRNA-binding protein that represses nucleophosmin translation. Oncogene. 2011;30:77&#x2013;86.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3190308</ArticleId><ArticleId IdType="pubmed">20802533</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng Y, Miskimins WK. Far upstream element binding protein 1 activates translation of p27Kip1 mRNA through its internal ribosomal entry site. Int J Biochem Cell Biol. 2011;43:1641&#x2013;1648.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3206725</ArticleId><ArticleId IdType="pubmed">21855647</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsushita K, Tomonaga T, Shimada H, Shioya A, Higashi M, Matsubara H, et al. An essential role of alternative splicing of c-myc suppressor FUSE-binding protein-interacting repressor in carcinogenesis. Cancer Res. 2006;66:1409&#x2013;1417.</Citation><ArticleIdList><ArticleId IdType="pubmed">16452196</ArticleId></ArticleIdList></Reference><Reference><Citation>Niforou KM, Anagnostopoulos AK, Vougas K, Kittas C, Gorgoulis VG, Tsangaris GT. The proteome profile of the human osteosarcoma U2OS cell line. Cancer Genomics Proteomics. 2008;5:63&#x2013;78.</Citation><ArticleIdList><ArticleId IdType="pubmed">18359981</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L, Yang H, Xu J. Gene expression significance in personalized medicine of non-small-cell lung cancer and gene expression analyzing platforms. Curr Drug Metab. 2011;12:455&#x2013;459.</Citation><ArticleIdList><ArticleId IdType="pubmed">21453275</ArticleId></ArticleIdList></Reference><Reference><Citation>Zubaidah RM, Tan GS, Tan SB, Lim SG, Lin Q, Chung MC. 2-D DIGE profiling of hepatocellular carcinoma tissues identified isoforms of far upstream binding protein (FUBP) as novel candidates in liver carcinogenesis. Proteomics. 2008;8:5086&#x2013;5096.</Citation><ArticleIdList><ArticleId IdType="pubmed">19003864</ArticleId></ArticleIdList></Reference><Reference><Citation>Bettegowda C, Agrawal N, Jiao Y, Sausen M, Wood LD, Hruban RH, et al. Mutations in CIC and FUBP1 contribute to human oligodendroglioma. Science. 2011;333:1453&#x2013;1455.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3170506</ArticleId><ArticleId IdType="pubmed">21817013</ArticleId></ArticleIdList></Reference><Reference><Citation>Malz M, Weber A, Singer S, Riehmer V, Bissinger M, Riener MO, et al. Overexpression of far upstream element binding proteins: a mechanism regulating proliferation and migration in liver cancer cells. Hepatology. 2009;50:1130&#x2013;1139.</Citation><ArticleIdList><ArticleId IdType="pubmed">19585652</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsushita K, Tomonaga T, Kajiwara T, Shimada H, Itoga S, Hiwasa T, et al. c-myc suppressor FBP-interacting repressor for cancer diagnosis and therapy. Front Biosci. 2009;14:3401&#x2013;3408.</Citation><ArticleIdList><ArticleId IdType="pubmed">19273283</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabenhorst U, Beinoraviciute-Kellner R, Brezniceanu ML, Joos S, Devens F, Lichter P, et al. Overexpression of the far upstream element binding protein 1 in hepatocellular carcinoma is required for tumor growth. Hepatology. 2009;50:1121&#x2013;1129.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3474328</ArticleId><ArticleId IdType="pubmed">19637194</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim MJ, Park BJ, Kang YS, Kim HJ, Park JH, Kang JW, et al. Downregulation of FUSE-binding protein and c-myc by tRNA synthetase cofactor p38 is required for lung cell differentiation. Nat Genet. 2003;34:330&#x2013;336.</Citation><ArticleIdList><ArticleId IdType="pubmed">12819782</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams BY, Hamilton SL, Sarkar HK. The survival motor neuron protein interacts with the transactivator FUSE binding protein from human fetal brain. FEBS Lett. 2000;470:207&#x2013;210.</Citation><ArticleIdList><ArticleId IdType="pubmed">10734235</ArticleId></ArticleIdList></Reference><Reference><Citation>Bentley DL, Groudine M. A block to elongation is largely responsible for decreased transcription of c-myc in differentiated HL60 cells. Nature. 1986;321:702&#x2013;706.</Citation><ArticleIdList><ArticleId IdType="pubmed">3520340</ArticleId></ArticleIdList></Reference><Reference><Citation>Westin EH, Wong-Staal F, Gelmann EP, Dalla-Favera R, Papas TS, Lautenberger JA, et al. Expression of cellular homologues of retroviral onc genes in human hematopoietic cells. Proc Natl Acad Sci USA. 1982;79:2490&#x2013;2494.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC346224</ArticleId><ArticleId IdType="pubmed">6283530</ArticleId></ArticleIdList></Reference><Reference><Citation>Bazar L, Harris V, Sunitha I, Hartmann D, Avigan M. A transactivator of c-myc is coordinately regulated with the proto-oncogene during cellular growth. Oncogene. 1995;10:2229&#x2013;2238.</Citation><ArticleIdList><ArticleId IdType="pubmed">7784068</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis-Smyth T, Duncan RC, Zheng T, Michelotti G, Levens D. The far upstream element-binding proteins comprise an ancient family of single-strand DNA-binding transactivators. J Biol Chem. 1996;271:31679&#x2013;31687.</Citation><ArticleIdList><ArticleId IdType="pubmed">8940189</ArticleId></ArticleIdList></Reference><Reference><Citation>Michelotti GA, Michelotti EF, Pullner A, Duncan RC, Eick D, Levens D. Multiple single-stranded cis elements are associated with activated chromatin of the human c-myc gene in vivo. Mol Cell Biol. 1996;16:2656&#x2013;2669.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC231256</ArticleId><ArticleId IdType="pubmed">8649373</ArticleId></ArticleIdList></Reference><Reference><Citation>Duncan R, Collins I, Tomonaga T, Zhang T, Levens D. A unique transactivation sequence motif is found in the carboxyl-terminal domain of the single-strandbinding protein FBP. Mol Cell Biol. 1996;16:2274&#x2013;2282.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC231215</ArticleId><ArticleId IdType="pubmed">8628294</ArticleId></ArticleIdList></Reference><Reference><Citation>Valverde R, Edwards L, Regan L. Structure and function of KH domains. FEBS J. 2008;275:2712&#x2013;2726.</Citation><ArticleIdList><ArticleId IdType="pubmed">18422648</ArticleId></ArticleIdList></Reference><Reference><Citation>Braddock DT, Baber JL, Levens D, Clore GM. Molecular basis of sequence-specific single-stranded DNA recognition by KH domains: solution structure of a complex between hnRNP K KH3 and single-stranded DNA. EMBO J. 2002;21:3476&#x2013;3485.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC126100</ArticleId><ArticleId IdType="pubmed">12093748</ArticleId></ArticleIdList></Reference><Reference><Citation>He L, Liu J, Collins I, Sanford S, O&#x2019;Connell B, Benham CJ, et al. Loss of FBP function arrests cellular proliferation and extinguishes c-myc expression. EMBO J. 2000;19:1034&#x2013;1044.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC305642</ArticleId><ArticleId IdType="pubmed">10698944</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J, Akoulitchev S, Weber A, Ge H, Chuikov S, Libutti D, et al. Defective interplay of activators and repressors with TFIH in xeroderma pigmentosum. Cell. 2001;104:353&#x2013;363.</Citation><ArticleIdList><ArticleId IdType="pubmed">11239393</ArticleId></ArticleIdList></Reference><Reference><Citation>Giglia-Mari G, Coin F, Ranish JA, Hoogstraten D, Theil A, Wijgers N, et al. A new, tenth subunit of TFIIH is responsible for the DNA repair syndrome trichothiodystrophy group A. Nat Genet. 2004;36:714&#x2013;719.</Citation><ArticleIdList><ArticleId IdType="pubmed">15220921</ArticleId></ArticleIdList></Reference><Reference><Citation>Tuteja N, Rahman K, Tuteja R, Falaschi A. Human DNA helicase V, a novel DNA unwinding enzyme from HeLa cells. Nucleic Acids Res. 1993;21:2323&#x2013;2329.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC309527</ArticleId><ArticleId IdType="pubmed">8389437</ArticleId></ArticleIdList></Reference><Reference><Citation>Vindigni A, Ochem A, Triolo G, Falaschi A. Identification of human DNA helicase V with the far upstream element-binding protein. Nucleic Acids Res. 2001;29:1061&#x2013;1067.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC29729</ArticleId><ArticleId IdType="pubmed">11222755</ArticleId></ArticleIdList></Reference><Reference><Citation>Costa M, Ochem A, Staub A, Falaschi A. Human DNA helicase VIII: a DNA and RNA helicase corresponding to the G3BP protein, an element of the ras transduction pathway. Nucleic Acids Res. 1999;27:817&#x2013;821.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC148252</ArticleId><ArticleId IdType="pubmed">9889278</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouchireb N, Clark MS. Human FUSE binding protein 3 gene (FBP3). Map position 9q33-34.1. Chromosome Res. 1999;7:577.</Citation><ArticleIdList><ArticleId IdType="pubmed">10598574</ArticleId></ArticleIdList></Reference><Reference><Citation>Gherzi R, Chen CY, Trabucchi M, Ramos A, Briata P. The role of KSRP in mRNA decay and microRNA precursor maturation. Wiley Interdiscip Rev RNA. 2010;1:230&#x2013;239.</Citation><ArticleIdList><ArticleId IdType="pubmed">21935887</ArticleId></ArticleIdList></Reference><Reference><Citation>Danckwardt S, Gantzert AS, Macher-Goeppinger S, Probst HC, Gentzel M, Wilm M, et al. p38 MAPK controls prothrombin expression by regulated RNA 3&#x2032; end processing. Mol Cell. 2011;41:298&#x2013;310.</Citation><ArticleIdList><ArticleId IdType="pubmed">21292162</ArticleId></ArticleIdList></Reference><Reference><Citation>Braddock DT, Louis JM, Baber JL, Levens D, Clore GM. Structure and dynamics of KH domains from FBP bound to single-stranded DNA. Nature. 2002;415:1051&#x2013;1056.</Citation><ArticleIdList><ArticleId IdType="pubmed">11875576</ArticleId></ArticleIdList></Reference><Reference><Citation>Benjamin LR, Chung HJ, Sanford S, Kouzine F, Liu J, Levens D. Hierarchical mechanisms build the DNA-binding specificity of FUSE binding protein. Proc Natl Acad Sci USA. 2008;105:18296&#x2013;18301.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2587613</ArticleId><ArticleId IdType="pubmed">19015535</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J, He L, Collins I, Ge H, Libutti D, Li J, et al. The FBP interacting repressor targets TFIIH to inhibit activated transcription. Mol Cell. 2000;5:331&#x2013;341.</Citation><ArticleIdList><ArticleId IdType="pubmed">10882074</ArticleId></ArticleIdList></Reference><Reference><Citation>Corsini L, Hothorn M, Stier G, Rybin V, Scheffzek K, Gibson TJ, et al. Dimerization and protein binding specificity of the U2AF homology motif of the splicing factor Puf60. J Biol Chem. 2009;284:630&#x2013;639.</Citation><ArticleIdList><ArticleId IdType="pubmed">18974054</ArticleId></ArticleIdList></Reference><Reference><Citation>Page-McCaw PS, Amonlirdviman K, Sharp PA. PUF60: a novel U2AF65-related splicing activity. RNA. 1999;5:1548&#x2013;1560.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1369877</ArticleId><ArticleId IdType="pubmed">10606266</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung HJ, Liu J, Dundr M, Nie Z, Sanford S, Levens D. FBPs are calibrated molecular tools to adjust gene expression. Mol Cell Biol. 2006;26:6584&#x2013;6597.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1592819</ArticleId><ArticleId IdType="pubmed">16914741</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsiao HH, Nath A, Lin CY, Folta-Stogniew EJ, Rhoades E, Braddock DT. Quantitative characterization of the interactions among c-myc transcriptional regulators FUSE, FBP, and FIR. Biochemistry. 2010;49:4620&#x2013;4634.</Citation><ArticleIdList><ArticleId IdType="pubmed">20420426</ArticleId></ArticleIdList></Reference><Reference><Citation>Weber A, Liu J, Collins I, Levens D. TFIIH operates through an expanded proximal promoter to fine-tune c-myc expression. Mol Cell Biol. 2005;25:147&#x2013;161.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC538784</ArticleId><ArticleId IdType="pubmed">15601838</ArticleId></ArticleIdList></Reference><Reference><Citation>Bazar L, Meighen D, Harris V, Duncan R, Levens D, Avigan M. Targeted melting and binding of a DNA regulatory element by a transactivator of c-myc. J Biol Chem. 1995;270:8241&#x2013;8248.</Citation><ArticleIdList><ArticleId IdType="pubmed">7713931</ArticleId></ArticleIdList></Reference><Reference><Citation>Krumm A, Meulia T, Brunvand M, Groudine M. The block to transcriptional elongation within the human c-myc gene is determined in the promoter-proximal region. Genes Dev. 1992;6:2201&#x2013;2213.</Citation><ArticleIdList><ArticleId IdType="pubmed">1427080</ArticleId></ArticleIdList></Reference><Reference><Citation>Levens D. How the c-myc promoter works and why it sometimes does not. J Natl Cancer Inst Monogr. 2008:41&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2683261</ArticleId><ArticleId IdType="pubmed">18648001</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J, Chung HJ, Vogt M, Jin Y, Malide D, He L, et al. JTV1 co-activates FBP to induce USP29 transcription and stabilize p53 in response to oxidative stress. EMBO J. 2011;30:846&#x2013;858.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3049210</ArticleId><ArticleId IdType="pubmed">21285945</ArticleId></ArticleIdList></Reference><Reference><Citation>Kusik BW, Hammond DR, Udvadia AJ. Transcriptional regulatory regions of gap43 needed in developing and regenerating retinal ganglion cells. Dev Dyn. 2010;239:482&#x2013;495.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3101714</ArticleId><ArticleId IdType="pubmed">20034105</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishizawa K, Okamoto H. Mutation analysis of the role for the carboxy-terminus encoding region in NGF-induced stabilization of GAP-43 mRNA. Biochem Biophys Res Commun. 1994;205:1380&#x2013;1385.</Citation><ArticleIdList><ArticleId IdType="pubmed">7802673</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W, Furneaux H, Cheng H, Caldwell MC, Hutter D, Liu Y, et al. HuR regulates p21 mRNA stabilization by UV light. Mol Cell Biol. 2000;20:760&#x2013;769.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC85192</ArticleId><ArticleId IdType="pubmed">10629032</ArticleId></ArticleIdList></Reference><Reference><Citation>Dean JL, Sully G, Clark AR, Saklatvala J. The involvement of AU-rich element-binding proteins in p38 mitogen-activated protein kinase pathway-mediated mRNA stabilisation. Cell Signal. 2004;16:1113&#x2013;1121.</Citation><ArticleIdList><ArticleId IdType="pubmed">15240006</ArticleId></ArticleIdList></Reference><Reference><Citation>Sully G, Dean JL, Wait R, Rawlinson L, Santalucia T, Saklatvala J, et al. Structural and functional dissection of a conserved destabilizing element of cyclo-oxygenase-2 mRNA: evidence against the involvement of AUF-1 [AU-rich element/poly(U)-binding/degradation factor-1], AUF-2, tristetraprolin, HuR (Hu antigen R) or FBP1 (far-upstream-sequence-element-binding protein 1) Biochem J. 2004;377:629&#x2013;639.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1223914</ArticleId><ArticleId IdType="pubmed">14594446</ArticleId></ArticleIdList></Reference><Reference><Citation>Colombo E, Alcalay M, Pelicci PG. Nucleophosmin and its complex network: a possible therapeutic target in hematological diseases. Oncogene. 2011;30:2595&#x2013;2609.</Citation><ArticleIdList><ArticleId IdType="pubmed">21278791</ArticleId></ArticleIdList></Reference><Reference><Citation>Grisendi S, Bernardi R, Rossi M, Cheng K, Khandker L, Manova K, et al. Role of nucleophosmin in embryonic development and tumorigenesis. Nature. 2005;437:147&#x2013;153.</Citation><ArticleIdList><ArticleId IdType="pubmed">16007073</ArticleId></ArticleIdList></Reference><Reference><Citation>Sportoletti P, Grisendi S, Majid SM, Cheng K, Clohessy JG, Viale A, et al. Npm1 is a haploinsufficient suppressor of myeloid and lymphoid malignancies in the mouse. Blood. 2008;111:3859&#x2013;3862.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2275037</ArticleId><ArticleId IdType="pubmed">18212245</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Z, Harris D, Pandey VN. The FUSE binding protein is a cellular factor required for efficient replication of hepatitis C virus. J Virol. 2008;82:5761&#x2013;5773.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2395142</ArticleId><ArticleId IdType="pubmed">18400844</ArticleId></ArticleIdList></Reference><Reference><Citation>Jang M, Park BC, Kang S, Chi SW, Cho S, Chung SJ, et al. Far upstream element-binding protein-1, a novel caspase substrate, acts as a cross-talker between apoptosis and the c-myc oncogene. Oncogene. 2009;28:1529&#x2013;1536.</Citation><ArticleIdList><ArticleId IdType="pubmed">19219071</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang PN, Lin JY, Locker N, Kung YA, Hung CT, Huang HI, et al. Far upstream element binding protein 1 binds the internal ribosomal entry site of enterovirus 71 and enhances viral translation and viral growth. Nucleic Acids Res. 2011;39:16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3239202</ArticleId><ArticleId IdType="pubmed">21880596</ArticleId></ArticleIdList></Reference><Reference><Citation>Balvay L, Soto RR, Ricci EP, Decimo D, Ohlmann T. Structural and functional diversity of viral IRESes. Biochim Biophys Acta. 2009;1789:542&#x2013;557.</Citation><ArticleIdList><ArticleId IdType="pubmed">19632368</ArticleId></ArticleIdList></Reference><Reference><Citation>He L, Weber A, Levens D. Nuclear targeting determinants of the far upstream element binding protein, a c-myc transcription factor. Nucleic Acids Res. 2000;28:4558&#x2013;4565.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC113884</ArticleId><ArticleId IdType="pubmed">11071946</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukumoto M, Sekimoto T, Yoneda Y. Proteomic analysis of importin alpha-interacting proteins in adult mouse brain. Cell Struct Funct. 2011;36:57&#x2013;67.</Citation><ArticleIdList><ArticleId IdType="pubmed">21307607</ArticleId></ArticleIdList></Reference><Reference><Citation>Buchan JR, Parker R. Eukaryotic stress granules: the ins and outs of translation. Mol Cell. 2009;36:932&#x2013;941.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2813218</ArticleId><ArticleId IdType="pubmed">20064460</ArticleId></ArticleIdList></Reference><Reference><Citation>Thiede B, Dimmler C, Siejak F, Rudel T. Predominant identification of RNA-binding proteins in Fas-induced apoptosis by proteome analysis. J Biol Chem. 2001;276:26044&#x2013;26050.</Citation><ArticleIdList><ArticleId IdType="pubmed">11352910</ArticleId></ArticleIdList></Reference><Reference><Citation>Milosevic J, Bulau P, Mortz E, Eickelberg O. Subcellular fractionation of TGF-beta1- stimulated lung epithelial cells: a novel proteomic approach for identifying signaling intermediates. Proteomics. 2009;9:1230&#x2013;1240.</Citation><ArticleIdList><ArticleId IdType="pubmed">19253281</ArticleId></ArticleIdList></Reference><Reference><Citation>Beretta L, Gingras AC, Svitkin YV, Hall MN, Sonenberg N. Rapamycin blocks the phosphorylation of 4E-BP1 and inhibits cap-dependent initiation of translation. EMBO J. 1996;15:658&#x2013;664.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC449984</ArticleId><ArticleId IdType="pubmed">8599949</ArticleId></ArticleIdList></Reference><Reference><Citation>Lasserre JP, Fack F, Revets D, Planchon S, Renaut J, Hoffmann L, et al. Effects of the endocrine disruptors atrazine and PCB 153 on the protein expression of MCF-7 human cells. J Proteome Res. 2009;8:5485&#x2013;5496.</Citation><ArticleIdList><ArticleId IdType="pubmed">19778091</ArticleId></ArticleIdList></Reference><Reference><Citation>Felty Q. Proteomic 2D DIGE profiling of human vascular endothelial cells exposed to environmentally relevant concentration of endocrine disruptor PCB153 and physiological concentration of 17beta-estradiol. Cell Biol Toxicol. 2011;27:49&#x2013;68.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3226797</ArticleId><ArticleId IdType="pubmed">20623170</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicolaides NC, Kinzler KW, Vogelstein B. Analysis of the 5&#x2019; region of PMS2 reveals heterogeneous transcripts and a novel overlapping gene. Genomics. 1995;29:329&#x2013;334.</Citation><ArticleIdList><ArticleId IdType="pubmed">8666379</ArticleId></ArticleIdList></Reference><Reference><Citation>Quevillon S, Robinson JC, Berthonneau E, Siatecka M, Mirande M. Macromolecular assemblage of aminoacyl-tRNA synthetases: identification of protein-protein interactions and characterization of a core protein. J Mol Biol. 1999;285:183&#x2013;195.</Citation><ArticleIdList><ArticleId IdType="pubmed">9878398</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo QM, Malek RL, Kim S, Chiao C, He M, Ruffy M, et al. Identification of c-myc responsive genes using rat cDNA microarray. Cancer Res. 2000;60:5922&#x2013;5928.</Citation><ArticleIdList><ArticleId IdType="pubmed">11085504</ArticleId></ArticleIdList></Reference><Reference><Citation>Ko HS, Kim SW, Sriram SR, Dawson VL, Dawson TM. Identification of far upstream element-binding protein-1 as an authentic Parkin substrate. J Biol Chem. 2006;281:16193&#x2013;16196.</Citation><ArticleIdList><ArticleId IdType="pubmed">16672220</ArticleId></ArticleIdList></Reference><Reference><Citation>Atanassov BS, Dent SY. USP22 regulates cell proliferation by deubiquitinating the transcriptional regulator FBP1. EMBO Rep. 2011;12:924&#x2013;930.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3166460</ArticleId><ArticleId IdType="pubmed">21779003</ArticleId></ArticleIdList></Reference><Reference><Citation>Weber A, Kristiansen I, Johannsen M, Oelrich B, Scholmann K, Gunia S, et al. The FUSE binding proteins FBP1 and FBP3 are potential c-myc regulators in renal, but not in prostate and bladder cancer. BMC Cancer. 2008;8:369.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2631590</ArticleId><ArticleId IdType="pubmed">19087307</ArticleId></ArticleIdList></Reference><Reference><Citation>Singer S, Malz M, Herpel E, Warth A, Bissinger M, Keith M, et al. Coordinated expression of stathmin family members by far upstream sequence element-binding protein-1 increases motility in non-small cell lung cancer. Cancer Res. 2009;69:2234&#x2013;2243.</Citation><ArticleIdList><ArticleId IdType="pubmed">19258502</ArticleId></ArticleIdList></Reference><Reference><Citation>Cleaver JE. Cancer in xeroderma pigmentosum and related disorders of DNA repair. Nat Rev Cancer. 2005;5:564&#x2013;573.</Citation><ArticleIdList><ArticleId IdType="pubmed">16069818</ArticleId></ArticleIdList></Reference><Reference><Citation>Man TK, Lu XY, Jaeweon K, Perlaky L, Harris CP, Shah S, et al. Genome-wide array comparative genomic hybridization analysis reveals distinct amplifications in osteosarcoma. BMC Cancer. 2004;4:45.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC514550</ArticleId><ArticleId IdType="pubmed">15298715</ArticleId></ArticleIdList></Reference><Reference><Citation>Engidawork E, Afjehi-Sadat L, Yang JW, Slavc I, Lubec G. Protein chemical identification and characterization of the human variants of far upstream element binding protein in medulloblastoma DAOY cell line. Int J Oncol. 2006;29:721&#x2013;736.</Citation><ArticleIdList><ArticleId IdType="pubmed">16865290</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100:57&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pubmed">10647931</ArticleId></ArticleIdList></Reference><Reference><Citation>Morrish F, Isern N, Sadilek M, Jeffrey M, Hockenbery DM. c-Myc activates multiple metabolic networks to generate substrates for cell-cycle entry. Oncogene. 2009;28:2485&#x2013;2491.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2779836</ArticleId><ArticleId IdType="pubmed">19448666</ArticleId></ArticleIdList></Reference><Reference><Citation>Mateyak MK, Obaya AJ, Sedivy JM. c-Myc regulates cyclin D-Cdk4 and -Cdk6 activity but affects cell cycle progression at multiple independent points. Mol Cell Biol. 1999;19:4672&#x2013;4683.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC84265</ArticleId><ArticleId IdType="pubmed">10373516</ArticleId></ArticleIdList></Reference><Reference><Citation>Dang CV, O&#x2019;Donnell KA, Zeller KI, Nguyen T, Osthus RC, Li F. The c-Myc target gene network. Semin Cancer Biol. 2006;16:253&#x2013;264.</Citation><ArticleIdList><ArticleId IdType="pubmed">16904903</ArticleId></ArticleIdList></Reference><Reference><Citation>Abbas T, Dutta A. p21 in cancer: intricate networks and multiple activities. Nat Rev Cancer. 2009;9:400&#x2013;414.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2722839</ArticleId><ArticleId IdType="pubmed">19440234</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao J, Zhang Z, Chen GG, Zhang M, Ding Y, Fu J, et al. Nucleophosmin/B23 interacts with p21WAF1/CIP1 and contributes to its stability. Cell Cycle. 2009;8:889&#x2013;895.</Citation><ArticleIdList><ArticleId IdType="pubmed">19221506</ArticleId></ArticleIdList></Reference><Reference><Citation>Colombo E, Bonetti P, Lazzerini Denchi E, Martinelli P, Zamponi R, Marine JC, et al. Nucleophosmin is required for DNA integrity and p19Arf protein stability. Mol Cell Biol. 2005;25:8874&#x2013;8886.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1265791</ArticleId><ArticleId IdType="pubmed">16199867</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo ML, den Besten W, Bertwistle D, Roussel MF, Sherr CJ. N-terminal poly-ubiquitination and degradation of the Arf tumor suppressor. Genes Dev. 2004;18:1862&#x2013;1874.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC517406</ArticleId><ArticleId IdType="pubmed">15289458</ArticleId></ArticleIdList></Reference><Reference><Citation>Millard SS, Yan JS, Nguyen H, Pagano M, Kiyokawa H, Koff A. Enhanced ribosomal association of p27(Kip1) mRNA is a mechanism contributing to accumulation during growth arrest. J Biol Chem. 1997;272:7093&#x2013;7098.</Citation><ArticleIdList><ArticleId IdType="pubmed">9054402</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolfer A, Wittner BS, Irimia D, Flavin RJ, Lupien M, Gunawardane RN, et al. MYC regulation of a &#x2018;poor-prognosis&#x2019; metastatic cancer cell state. Proc Natl Acad Sci USA. 2010;107:3698&#x2013;3703.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2840447</ArticleId><ArticleId IdType="pubmed">20133671</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolfer A, Ramaswamy S. MYC and metastasis. Cancer Res. 2011;71:2034&#x2013;2037.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3089000</ArticleId><ArticleId IdType="pubmed">21406394</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan S, Zhou C, Lou X, Xiao Z, Zhu H, Wang Q, et al. PTTG overexpression promotes lymph node metastasis in human esophageal squamous cell carcinoma. Cancer Res. 2009;69:3283&#x2013;3290.</Citation><ArticleIdList><ArticleId IdType="pubmed">19351864</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith AP, Verrecchia A, Faga G, Doni M, Perna D, Martinato F, et al. A positive role for Myc in TGFbeta-induced Snail transcription and epithelial-to-mesenchymal transition. Oncogene. 2009;28:422&#x2013;430.</Citation><ArticleIdList><ArticleId IdType="pubmed">18978814</ArticleId></ArticleIdList></Reference><Reference><Citation>Peinado H, Olmeda D, Cano A. Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat Rev Cancer. 2007;7:415&#x2013;428.</Citation><ArticleIdList><ArticleId IdType="pubmed">17508028</ArticleId></ArticleIdList></Reference><Reference><Citation>Karst AM, Levanon K, Duraisamy S, Liu JF, Hirsch MS, Hecht JL, et al. Stathmin 1, a marker of PI3K pathway activation and regulator of microtubule dynamics, is expressed in early pelvic serous carcinomas. Gynecol Oncol. 2011;123:8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3171572</ArticleId><ArticleId IdType="pubmed">21683992</ArticleId></ArticleIdList></Reference><Reference><Citation>Rana S, Maples PB, Senzer N, Nemunaitis J. Stathmin 1: a novel therapeutic target for anticancer activity. Expert Rev Anticancer Ther. 2008;8:1461&#x2013;1470.</Citation><ArticleIdList><ArticleId IdType="pubmed">18759697</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu SG, Yan PJ, Shao ZM. Differential proteomic analysis of a highly metastatic variant of human breast cancer cells using two-dimensional differential gel electrophoresis. J Cancer Res Clin Oncol. 2010;136:1545&#x2013;1556.</Citation><ArticleIdList><ArticleId IdType="pubmed">20155427</ArticleId></ArticleIdList></Reference><Reference><Citation>Huth JR, Yu L, Collins I, Mack J, Mendoza R, Isaac B, et al. NMR-driven discovery of benzoylanthranilic acid inhibitors of far upstream element binding protein binding to the human oncogene c-myc promoter. J Med Chem. 2004;47:4851&#x2013;4857.</Citation><ArticleIdList><ArticleId IdType="pubmed">15369388</ArticleId></ArticleIdList></Reference><Reference><Citation>Stoneley M, Willis AE. Cellular internal ribosome entry segments: structures, trans-acting factors and regulation of gene expression. Oncogene. 2004;23:3200&#x2013;3207.</Citation><ArticleIdList><ArticleId IdType="pubmed">15094769</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>